http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2200578-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-79 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate | 1995-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_213c28e1175caf46713d15a6316a2d87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb82354f170ed7f3cf80304eb7fcc6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5adc67e1c0c8ef0529654e3966664a80 |
| publicationDate | 1996-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2200578-A1 |
| titleOfInvention | N-substituted piperidinyl bicyclic benzoate derivatives |
| abstract | The present invention is concerned with novel benzoate derivatives laving formula (I), the N-oxide forms, the salts and the stereochemically isomeric forms thereof, wherein: R1 is halo or C1-6alkylsulfonylamino; A represents a bivalent radical of formula -CH2-CH2- (a), -CH2CH2-CH2-(b), -CH-CH- (c), in the radicals (a), (b) and (c) one or two hydrogen atoms may be replaced by a C1-6alkyl; R2 is hydrogen or C1-6alkyloxy; L is a radical of formula: -Alk-R4 (d), -Alk-O-R5 (e) -Alk-NR6R7 (f), Alk is C1-12alkanediyl; R4 is hydrogen; cyano; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; C3-7cycloalkyl; C1-6alkylsulfinyl; C1-6alkylsulfonyl; phenyl or phenyl substituted with halo, C1-6alkyl or C1-6alkyloxy; tetrahydrofuran; dioxolane; dioxolane substituted with C1-6alkyl; dioxane; dioxane substituted with C1-6alkyl; pyridine; pyridine substituted with halo or C1-6alkyl; pyridazine; pyridazine substituted with one or two substituents selected from halo, C1-6alkyl, hydroxy or an optionally substituted benzimidazolone or an optionally substituted imidazolone; R5 is hydrogen; C1-6alkyl; hydroxyC1-6alkyl; C1-6alkylcarbonyl; phenyl or phenyl substituted with up to three substituents selected from halo, C1-6alkyl, C1-6alkyloxy; R6 is hydrogen or C1-6alkyl; R7 is hydrogen; C1-6alkyl; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; pyridazine; pyridazine substituted with one or two substituents selected from halo, C1-6alkyl, hydroxy; pyrazine; pyrazine substituted with one or two substituents selected from halo, C1-6alkyl, hydroxy. Pharmaceutical compositions comprising said compounds, processes for preparing compounds and compositions as well as the use as a medicine, in particular for the treatment of gastrointestinal disorders involving a decreased colon motility are described. |
| priorityDate | 1994-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.